Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Assessing drug elution technologies in the superficial femoral artery.

Owens CD, Gasper WJ, Conte MS.

Panminerva Med. 2011 Mar;53(1):37-49.

PMID:
21346703
2.

Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.

Doostzadeh J, Clark LN, Bezenek S, Pierson W, Sood PR, Sudhir K.

Coron Artery Dis. 2010 Jan;21(1):46-56. doi: 10.1097/MCA.0b013e328333f550. Review.

PMID:
19952925
3.

Drug-eluting stents.

García-García HM, Vaina S, Tsuchida K, Serruys PW.

Arch Cardiol Mex. 2006 Jul-Sep;76(3):297-319. Review.

PMID:
17091802
4.

Molecular mechanisms of restenosis after percutaneous peripheral angioplasty and approach to endovascular therapy.

Mongiardo A, Curcio A, Spaccarotella C, Parise S, Indolfi C.

Curr Drug Targets Cardiovasc Haematol Disord. 2004 Sep;4(3):275-87. Review.

PMID:
15379621
5.
6.

Superficial femoral artery: current treatment options.

Tepe G, Schmehl J, Heller S, Wiesinger B, Claussen CD, Duda SH.

Eur Radiol. 2006 Jun;16(6):1316-22. Epub 2006 Feb 18. Review.

PMID:
16489440
7.

Efficacy and safety of drug-eluting stents: current best available evidence.

Raja SG, Dreyfus GD.

J Card Surg. 2006 Nov-Dec;21(6):605-12; discussion 613-4. Review.

PMID:
17073969
8.

Restenosis after stenting of atherosclerotic renal artery stenosis: is there a rationale for the use of drug-eluting stents?

Zeller T, Rastan A, Rothenpieler U, Müller C.

Catheter Cardiovasc Interv. 2006 Jul;68(1):125-30. Review.

PMID:
16755597
9.

Expert consensus (SBC/SBHCI) on the use of drug-eluting stents: recommendations of the Brazilian society of interventional cardiology/ Brazilian society of cardiology for the Brazilian public single healthcare system.

Lima VC, Mattos LA, Caramori PR, Perin MA, Mangione JA, Machado BM, Coelho WM, Bueno RR.

Arq Bras Cardiol. 2006 Oct;87(4):e162-7. Review. English, Portuguese.

10.

Choosing a drug-eluting stent: a comparison between CYPHER and TAXUS.

Perin EC.

Rev Cardiovasc Med. 2005;6 Suppl 1:S13-21. Review.

PMID:
15665793
11.

Percutaneous vascular interventions in the superficial femoral artery. A review.

Wiesinger B, Heller S, Schmehl J, Claussen CD, Wiskirchen J, Tepe G.

Minerva Cardioangiol. 2006 Feb;54(1):83-93. Review.

PMID:
16467744
12.

Covered stenting of the superficial femoral artery using the Viabahn stent-graft.

Geraghty PJ.

Perspect Vasc Surg Endovasc Ther. 2006 Mar;18(1):39-43. Review.

PMID:
16628330
13.

Paclitaxel-eluting stents: current clinical experience.

Grube E, Buellesfeld L.

Am J Cardiovasc Drugs. 2004;4(6):355-60. Review.

PMID:
15554720
14.

Optimal therapeutic approaches to femoropopliteal artery intervention.

Das T.

Catheter Cardiovasc Interv. 2004 Sep;63(1):21-30. Review.

PMID:
15343563
15.

Current status of bare and drug-eluting stents in infrainguinal peripheral vascular disease.

Schmehl J, Tepe G.

Expert Rev Cardiovasc Ther. 2008 Apr;6(4):531-8. doi: 10.1586/14779072.6.4.531. Review.

PMID:
18402542
16.

Drug-eluting stents for infrainguinal occlusive disease: progress and challenges.

Tepe G.

Semin Vasc Surg. 2006 Jun;19(2):102-8. Review.

PMID:
16782516
17.

Drug-eluting stents: a multidisciplinary success story.

Burt HM, Hunter WL.

Adv Drug Deliv Rev. 2006 Jun 3;58(3):350-7. Epub 2006 Mar 20. Review.

PMID:
16546288
18.

How to interpret data from the superficial femoral artery stenting trials and registries.

Lin PH, Weakley SM, Kougias P.

Semin Vasc Surg. 2010 Sep;23(3):138-47. doi: 10.1053/j.semvascsurg.2010.05.001. Review.

PMID:
20826290
19.

Sirolimus-eluting coronary stent.

Vishnevetsky D, Patel P, Tijerino H, Gandhi PJ.

Am J Health Syst Pharm. 2004 Mar 1;61(5):449-56. Review.

PMID:
15018222
20.

Drug-eluting stents for cardiovascular disorders.

Granada JF, Kaluza GL, Raizner A.

Curr Atheroscler Rep. 2003 Jul;5(4):308-16. Review.

PMID:
12793972

Supplemental Content

Support Center